Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.29
-0.52 (-8.95%)
Mar 31, 2025, 4:00 PM EDT - Market closed

Recursion Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-463.66-328.07-239.48-186.48-87.01
Upgrade
Depreciation & Amortization
36.4924.411.768.413.94
Upgrade
Asset Writedown & Restructuring Costs
0.111.192.81-0.87
Upgrade
Stock-Based Compensation
81.6953.527.9114.844.29
Upgrade
Other Operating Activities
24.211.458.564.921.66
Upgrade
Change in Accounts Receivable
-6.07-7.76-0-5.38-1.12
Upgrade
Change in Accounts Payable
6.44-0.991.771.75-0.19
Upgrade
Change in Unearned Revenue
-28.04-41.08110.32-1026.67
Upgrade
Change in Other Net Operating Assets
-10.33-0.44-7.1613.335.47
Upgrade
Operating Cash Flow
-359.17-287.78-83.52-158.61-45.4
Upgrade
Capital Expenditures
-13.7-11.96-37.06-39.8-5.83
Upgrade
Cash Acquisitions
277.11.84---2.6
Upgrade
Sale (Purchase) of Intangibles
-3.35-0.6-0.3--0.9
Upgrade
Investment in Securities
-0.48230.61-231.95-
Upgrade
Other Investing Activities
----0.6
Upgrade
Investing Cash Flow
260.06-10.23193.25-271.74-8.74
Upgrade
Long-Term Debt Issued
----6.4
Upgrade
Long-Term Debt Repaid
-4.44-0.77-0.09-12.8-0.08
Upgrade
Net Debt Issued (Repaid)
-4.44-0.77-0.09-12.86.32
Upgrade
Issuance of Common Stock
308.56140.9154.44471.340.68
Upgrade
Financing Cash Flow
304.12140.13154.35458.54246.14
Upgrade
Foreign Exchange Rate Adjustments
-3.410.19-0.31--
Upgrade
Net Cash Flow
201.6-157.69263.7628.18192
Upgrade
Free Cash Flow
-372.87-299.74-120.58-198.41-51.23
Upgrade
Free Cash Flow Margin
-633.71%-672.43%-302.64%-1949.42%-1293.03%
Upgrade
Free Cash Flow Per Share
-1.36-1.44-0.69-1.58-2.35
Upgrade
Cash Interest Paid
---0.680.99
Upgrade
Levered Free Cash Flow
-194.33-187.37-105.41-121.93-34.61
Upgrade
Unlevered Free Cash Flow
-193.35-187.31-105.37-120.09-33.76
Upgrade
Change in Net Working Capital
-4.8933.87-45.9-10.7-17.62
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q